BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres MDT, Cao J, Franco OL, Lu TK, de la Fuente-Nunez C. Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery. ACS Nano 2021;15:2143-64. [PMID: 33538585 DOI: 10.1021/acsnano.0c09509] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Arqué X, Torres MDT, Patiño T, Boaro A, Sánchez S, de la Fuente-Nunez C. Autonomous Treatment of Bacterial Infections in Vivo Using Antimicrobial Micro- and Nanomotors. ACS Nano 2022. [PMID: 35486889 DOI: 10.1021/acsnano.1c11013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chen X, Han H, Tang Z, Jin Q, Ji J. Aggregation-Induced Emission-Based Platforms for the Treatment of Bacteria, Fungi, and Viruses. Adv Healthc Mater 2021;10:e2100736. [PMID: 34190431 DOI: 10.1002/adhm.202100736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 He W, Jiang Y, Jin J, Li Z, Zhao J, Manavalan B, Su R, Gao X, Wei L. Accelerating bioactive peptide discovery via mutual information-based meta-learning. Brief Bioinform 2021:bbab499. [PMID: 34882225 DOI: 10.1093/bib/bbab499] [Reference Citation Analysis]
4 Hao Y, Wang J, de la Fuente-Nunez C, Franco OL. Editorial: Antimicrobial Peptides: Molecular Design, Structure-Function Relationship, and Biosynthesis Optimization. Front Microbiol 2022;13:888540. [PMID: 35495692 DOI: 10.3389/fmicb.2022.888540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cesaro A, Torres MDT, Gaglione R, Dell'Olmo E, Di Girolamo R, Bosso A, Pizzo E, Haagsman HP, Veldhuizen EJA, de la Fuente-Nunez C, Arciello A. Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma. ACS Nano 2022;16:1880-95. [PMID: 35112568 DOI: 10.1021/acsnano.1c04496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Torres MDT, Melo MCR, Crescenzi O, Notomista E, de la Fuente-Nunez C. Mining for encrypted peptide antibiotics in the human proteome. Nat Biomed Eng 2021. [PMID: 34737399 DOI: 10.1038/s41551-021-00801-1] [Reference Citation Analysis]
7 Robles-loaiza AA, Pinos-tamayo EA, Mendes B, Ortega-pila JA, Proaño-bolaños C, Plisson F, Teixeira C, Gomes P, Almeida JR. Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity. Pharmaceuticals 2022;15:323. [DOI: 10.3390/ph15030323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vrancianu CO, Dobre EG, Gheorghe I, Barbu I, Cristian RE, Chifiriuc MC. Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections. Microorganisms 2021;9:730. [PMID: 33807464 DOI: 10.3390/microorganisms9040730] [Reference Citation Analysis]
9 Aronson MR, Ali Akbari Ghavimi S, Gehret PM, Jacobs IN, Gottardi R. Drug-Eluting Endotracheal Tubes for Preventing Bacterial Inflammation in Subglottic Stenosis. Laryngoscope 2021. [PMID: 34319583 DOI: 10.1002/lary.29769] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tan P, Tang Q, Xu S, Zhang Y, Fu H, Ma X. Designing Self-Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections. Adv Sci (Weinh) 2022;9:e2105955. [PMID: 35285170 DOI: 10.1002/advs.202105955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ageitos L, de la Fuente-Nunez C. Antimicrobial Peptides: Potential Therapeutics Against Drug-Resistant Pulmonary Infections. Arch Bronconeumol 2021. [PMID: 34642532 DOI: 10.1016/j.arbres.2021.09.007] [Reference Citation Analysis]
12 Mejía-Pitta A, Broset E, de la Fuente-Nunez C. Probiotic engineering strategies for the heterologous production of antimicrobial peptides. Adv Drug Deliv Rev 2021;176:113863. [PMID: 34273423 DOI: 10.1016/j.addr.2021.113863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Oliveira CS, Torres MT, Pedron CN, Andrade VB, Silva PI Jr, Silva FD, de la Fuente-Nunez C, Oliveira VX Jr. Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal Model. ACS Infect Dis 2021;7:2736-45. [PMID: 34463484 DOI: 10.1021/acsinfecdis.1c00261] [Reference Citation Analysis]